keyword
https://read.qxmd.com/read/38444561/hepatitis-delta-virus-infection-in-turkey-a-meta-analysis-of-prevalence
#21
JOURNAL ARTICLE
Mehlika Toy, Begüm Güler, Kayra Somay, Genco Gençdal, Cihan Yurdaydin
OBJECTIVES: Hepatitis delta virus (HDV) infection has been granted orphan disease status by the US Food and Drug Administration and the European Medicines Agency owing to its rarity and relatively limited research and treatment options. Turkey is considered an endemic country for the virus. We aimed to provide a current and updated country- and region-specific HDV infection prevalence. METHODS: In this meta-analysis, we searched databases, including MEDLINE, PUBMED, EMBASE, and UlakBim (Turkish Medical Index) published between January 1, 2006, and December 31, 2022...
March 2024: IJID Reg
https://read.qxmd.com/read/38421275/ictv-virus-taxonomy-profile-kolmioviridae-2024
#22
JOURNAL ARTICLE
Jens H Kuhn, Artem Babaian, Laura M Bergner, Paul Dény, Dieter Glebe, Masayuki Horie, Eugene V Koonin, Mart Krupovic, Sofia Paraskevopoulou, Marcos de la Peña, Teemu Smura, Jussi Hepojoki
Kolmioviridae is a family for negative-sense RNA viruses with circular, viroid-like genomes of about 1.5-1.7 kb that are maintained in mammals, amphibians, birds, fish, insects and reptiles. Deltaviruses, for instance, can cause severe hepatitis in humans. Kolmiovirids encode delta antigen (DAg) and replicate using host-cell DNA-directed RNA polymerase II and ribozymes encoded in their genome and antigenome. They require evolutionary unrelated helper viruses to provide envelopes and incorporate helper virus proteins for infectious particle formation...
February 2024: Journal of General Virology
https://read.qxmd.com/read/38404959/delta-hepatitis-in-the-united-states-epidemiology-testing-and-linkage-to-care
#23
JOURNAL ARTICLE
Robert G Gish
No abstract text is available yet for this article.
October 2023: Gastroenterology & Hepatology
https://read.qxmd.com/read/38396738/hydroxypropyl-beta-cyclodextrin-barrier-prevents-respiratory-viral-infections-a-preclinical-study
#24
JOURNAL ARTICLE
Angela Lu, Brandon Ebright, Aditya Naik, Hui L Tan, Noam A Cohen, Jean-Marie C Bouteiller, Gianluca Lazzi, Stan G Louie, Mark S Humayun, Isaac Asante
The emergence and mutation of pathogenic viruses have been occurring at an unprecedented rate in recent decades. The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into a global public health crisis due to extensive viral transmission. In situ RNA mapping has revealed angiotensin-converting enzyme 2 (ACE2) expression to be highest in the nose and lower in the lung, pointing to nasal susceptibility as a predominant route for infection and the cause of subsequent pulmonary effects...
February 8, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38390020/-delta-hepatitis-in-africa-epidemiological-and-clinical-particularities
#25
JOURNAL ARTICLE
Françoise Lunel Fabiani, Ahmed El Bara, Cheikh Tijani Hamed, Hélène LE Guillou Guillemette
In 2022, the World Health Organization (WHO) estimated that hepatitis B virus (HBV) infections caused 1.5 million deaths, mostly attributable to complications from chronic infections, cirrhosis and hepatocellular carcinoma (HCC). Despite the availability of a vaccine, 296 million people were chronically infected in 2019. Asia and Africa are the continents most affected by this infection, with around 100 million people infected in Africa as a whole.Hepatitis Delta or D virus (HDV), which is a "satellite" virus of HBV, is often misunderstood and its diagnosis remains neglected...
December 31, 2023: Med Trop Sante Int
https://read.qxmd.com/read/38380011/genistein-and-sex-hormone-treatment-alleviated-hepatic-fat-accumulation-and-inflammation-in-orchidectomized-rats-with-nonalcoholic-steatohepatitis
#26
JOURNAL ARTICLE
Fatist Okrit, Maneerat Chayanupatkul, Natcha Wanpiyarat, Prasong Siriviriyakul, Duangporn Werawatganon
Testosterone deficiency has been reported to accelerate nonalcoholic fatty liver disease (NAFLD). However, there are minimal data on the risk of NAFLD in transgender women and the treatment of NAFLD in this population. This study aimed to investigate the treatment effects and the mechanisms of action of genistein and sex hormones in orchiectomized (ORX) rats with nonalcoholic steatohepatitis (NASH) induced by a high fat high fructose diet (HFHF). Seven-week old male Sprague-Dawley rats were randomly divided into 7 groups (n = 6 each group); 1) control group, 2) ORX + standard diet group, 3) HFHF group, 4) ORX + HFHF group, 5) ORX + HFHF diet + testosterone group (50 mg/kg body weight (BW) once weekly), 6) ORX + HFHF diet + estradiol group (1...
February 29, 2024: Heliyon
https://read.qxmd.com/read/38378708/identification-of-hdv-like-theta-ribozymes-involved-in-trna-based-recoding-of-gut-bacteriophages
#27
JOURNAL ARTICLE
Kasimir Kienbeck, Lukas Malfertheiner, Susann Zelger-Paulus, Silke Johannsen, Christian von Mering, Roland K O Sigel
Trillions of microorganisms, collectively known as the microbiome, inhabit our bodies with the gut microbiome being of particular interest in biomedical research. Bacteriophages, the dominant virome constituents, can utilize suppressor tRNAs to switch to alternative genetic codes (e.g., the UAG stop-codon is reassigned to glutamine) while infecting hosts with the standard bacterial code. However, what triggers this switch and how the bacteriophage manipulates its host is poorly understood. Here, we report the discovery of a subgroup of minimal hepatitis delta virus (HDV)-like ribozymes - theta ribozymes - potentially involved in the code switch leading to the expression of recoded lysis and structural phage genes...
February 20, 2024: Nature Communications
https://read.qxmd.com/read/38361436/protein-kinase-c-delta-enhances-the-diagnostic-performance-of-hepatocellular%C3%A2-carcinoma
#28
JOURNAL ARTICLE
Chika Nakagawa, Tsunekazu Oikawa, Kohji Yamada, Akihito Tsubota, Chisato Saeki, Kuniko Katagiri, Naoko Tago, Hiroshi Kamioka, Kaoru Ueda, Koichiro Haruki, Kenei Furukawa, Masanori Nakano, Yuichi Torisu, Toru Ikegami, Kiyotsugu Yoshida, Masayuki Saruta
BACKGROUND: The conventional markers for hepatocellular carcinoma (HCC), α-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP), have several limitations; both have low sensitivity in patients with early-stage HCC; low sensitivity for AFP with HCC after eliminating hepatitis C virus (HCV); low specificity for DCP in patients with non-viral HCC, which is increasing worldwide; low specificity for AFP in patients with liver injury; and low specificity for DCP in patients treated with warfarin...
February 15, 2024: Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
https://read.qxmd.com/read/38350177/impact-of-anti-hdv-reflex-testing-at-hbs-antigen-positive-discovery-in-a-single-center-france-support-for-primary-hdv-screening-in-france
#29
JOURNAL ARTICLE
Assilina Parfut, Simona Tripon, Pierre Gantner, Fréderic Chaffraix, Elodie Laugel, Marie-Josée Wendling, Furkan Erol, Carine Wiedemer, Michel Doffoel, Antonio Saviano, Maude Royant, François Habersetzer, Samira Fafi-Kremer, Aurélie Velay
BACKGROUND: Hepatitis Delta virus (HDV) infection is a major cause of liver-related morbidity and mortality in patients infected with HBV, with a global HDV prevalence uncertain. In France, 2 to 5 % of HBs antigen (HBsAg) carriers present anti-HDV antibodies (anti-HDV). The EASL recommends testing for anti-HDV in all HBsAg-positive patients. Since January 2022, we have systematically carried out anti-HDV serology when a positive HBsAg is discovered (new HBsAg carriers). OBJECTIVES: We evaluated the benefit of anti-HDV reflex testing after one year of practice by comparing anti-HDV and HBsAg serology data over the last six years, among the new HBsAg carriers and all the HBsAg carriers...
February 3, 2024: Journal of Clinical Virology
https://read.qxmd.com/read/38340811/blocking-viral-entry-with-bulevirtide-reduces-the-number-of-hdv-infected-hepatocytes-in-human-liver-biopsies
#30
JOURNAL ARTICLE
Lena Allweiss, Annika Volmari, Vithika Suri, Jeffrey J Wallin, John F Flaherty, Dmitry Manuilov, Bryan Downie, Marc Lütgehetmann, Jan-Hendrik Bockmann, Stephan Urban, Heiner Wedemeyer, Maura Dandri
BACKGROUND & AIMS: Bulevirtide (BLV) is a first-in-class entry inhibitor and the only approved treatment for patients chronically infected with HDV in Europe. We aimed to investigate the efficacy of BLV treatment in paired liver biopsies obtained at baseline and after 24 or 48 weeks of treatment. METHODS: We performed a combined analysis of 126 paired liver biopsies derived from 3 clinical trials. In the phase 2 clinical trial MYR202, patients with chronic hepatitis D were randomised to receive 24 weeks of BLV at 2mg, 5mg or 10mg/day...
February 8, 2024: Journal of Hepatology
https://read.qxmd.com/read/38332002/drug-repurposing-screen-identifies-lonafarnib-as-respiratory-syncytial-virus-fusion-protein-inhibitor
#31
JOURNAL ARTICLE
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna K H Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infection in infants, older adults and the immunocompromised. Effective directly acting antivirals are not yet available for clinical use. To address this, we screen the ReFRAME drug-repurposing library consisting of 12,000 small molecules against RSV. We identify 21 primary candidates including RSV F and N protein inhibitors, five HSP90 and four IMPDH inhibitors. We select lonafarnib, a licensed farnesyltransferase inhibitor, and phase III candidate for hepatitis delta virus (HDV) therapy, for further follow-up...
February 8, 2024: Nature Communications
https://read.qxmd.com/read/38315140/the-rivet-rct-rifamycin-sv-mmx-improves-muscle-mass-physical-function-and-ammonia-in-cirrhosis-and-minimal-encephalopathy
#32
JOURNAL ARTICLE
Jasmohan S Bajaj, Andrew Fagan, Edith A Gavis, Travis Mousel, Mary L Gallagher, Puneet Puri, Michael Fuchs, Brian C Davis, Phillip B Hylemon, Huiping Zhou, Vishwadeep Ahluwalia, Robert Cadrain, Masoumeh Sikaroodi, Patrick M Gillevet
BACKGROUND: Minimal hepatic encephalopathy (MHE) negatively affects the prognosis of cirrhosis, but treatment is not standard. Rifamycin SV MMX (RiVM) is a nonabsorbable rifampin derivative with colonic action. METHODS: In a phase 2 placebo-controlled, double-blind randomized clinical trial patients with MHE were randomized to RiVM or placebo for 30 days with a 7-day follow-up. The primary endpoint was a change in stool cirrhosis dysbiosis ratio. Gut-brain (cognition, stool/salivary microbiome, ammonia, brain magnetic resonance spectroscopy), inflammation (stool calprotectin/serum cytokines), patient-reported outcomes (sickness impact profile: total/physical/psychosocial, high = worse), and sarcopenia (handgrip, bioelectric impedance) were secondary...
February 1, 2024: Hepatology Communications
https://read.qxmd.com/read/38284014/abundance-of-g-quadruplex-forming-sequences-in-the-hepatitis-delta-virus-genomes
#33
JOURNAL ARTICLE
Václav Brázda, Natália Valková, Michaela Dobrovolná, Jean-Louis Mergny
Hepatitis delta virus (HDV) is a highly unusual RNA satellite virus that depends on the presence of hepatitis B virus (HBV) to be infectious. Its compact and variable single-stranded RNA genome consists of eight major genotypes distributed unevenly across different continents. The significance of noncanonical secondary structures such as G-quadruplexes (G4s) is increasingly recognized at the DNA and RNA levels, particularly for transcription, replication, and translation. G4s are formed from guanine-rich sequences and have been identified in the vast majority of viral, eukaryotic, and prokaryotic genomes...
January 23, 2024: ACS Omega
https://read.qxmd.com/read/38276268/potential-biomarkers-for-the-earlier-diagnosis-of-kidney-and-liver-damage-in-acute-intermittent-porphyria
#34
JOURNAL ARTICLE
Elin Storjord, Staffan Wahlin, Bård Ove Karlsen, Randolf I Hardersen, Amy K Dickey, Judith K Ludviksen, Ole-Lars Brekke
Acute intermittent porphyria (AIP) is an inherited metabolic disorder associated with complications including kidney failure and hepatocellular carcinoma, probably caused by elevations in the porphyrin precursors porphobilinogen (PBG) and delta-aminolevulinic acid (ALA). This study explored differences in modern biomarkers for renal and hepatic damage between AIP patients and controls. Urine PBG testing, kidney injury panels, and liver injury panels, including both routine and modern biomarkers, were performed on plasma and urine samples from AIP cases and matched controls (50 and 48 matched pairs, respectively)...
December 21, 2023: Life
https://read.qxmd.com/read/38271697/enrichment-reveals-extensive-integration-of-hepatitis-b-virus-dna-in-hepatitis-delta-infected-patients
#35
JOURNAL ARTICLE
Johan Ringlander, Lucia Gonzales Strömberg, Joakim B Stenbäck, Maria E Andersson, Sanna Abrahamsson, Catarina Skoglund, Maria Castedal, Simon B Larsson, Gustaf E Rydell, Magnus Lindh
INTRODUCTION: Hepatitis B virus (HBV) DNA may become integrated into the human genome of infected human hepatocytes. Expression of integrations can produce the surface antigen (HBsAg) that is required for synthesis of hepatitis D virus (HDV) particles and the abundant subviral particles in the blood of HBV- and HDV-infected subjects. Knowledge about the extent and variation of HBV integrations and impact on chronic HDV is still limited. METHODS: We investigated 50 pieces of liver explant tissue from five patients with hepatitis D-induced cirrhosis, using a deep sequencing strategy targeting HBV RNA...
January 25, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38247385/quantification-of-serum-hdv-rna-by-robogene-2-0-in-hdv-patients-is-significantly-influenced-by-the-extraction-methods
#36
JOURNAL ARTICLE
Maria Paola Anolli, Sara Uceda Renteria, Elisabetta Degasperi, Marta Borghi, Floriana Facchetti, Dana Sambarino, Riccardo Perbellini, Sara Monico, Ferruccio Ceriotti, Pietro Lampertico
BACKGROUND AND AIM: Management of chronic hepatitis delta (CHD) requires reliable tests for HDV RNA quantification. The aim of the study was to compare two extraction methods for the quantification of HDV RNA in untreated and bulevirtide (BLV)-treated CHD patients. METHODS: Frozen sera from untreated and BLV-treated CHD patients were tested in a single-centre study for HDV RNA levels (Robogene 2.0, Roboscreen GmbH, Leipzig, Germany; LOD 6 IU/mL) with two extraction methods: manual (INSTANT Virus RNA/DNA kit; Roboscreen GmbH, Leipzig, Germany) versus automated (EZ1 DSP Virus Kit; Qiagen, Hilden, Germany)...
January 22, 2024: Liver International: Official Journal of the International Association for the Study of the Liver
https://read.qxmd.com/read/38231098/-gastroenterology-and-hepatology-what-s-new-in-2023
#37
JOURNAL ARTICLE
Montserrat Fraga, Jeanine Wakim El-Khoury, Sarra Oumrani, Sébastien Godat, Julien Vionnet, Alain Schoepfer, Joana Vieira Barbosa
2023 has been marked by numerous advancements in the fields of hepatology, liver transplantation, gastroenterology, and interventional endoscopy. These developments hold the promise of changing our daily practice while enhancing the diagnosis and treatment of various hepatic and gastroenterological conditions. Additionally, the European Association for the Study of the Liver (EASL) has issued recommendations for the management of hepatitis delta, acute-on-chronic liver failure, liver diseases of pregnancy, and intrahepatic cholangiocarcinoma...
January 17, 2024: Revue Médicale Suisse
https://read.qxmd.com/read/38228543/-expert-consensus-on-vaccinations-in-adult-patients-with-autoimmune-rheumatic-diseases-in-china-2023-edition
#38
JOURNAL ARTICLE
(no author information available yet)
Vaccination is one of the critical tools to prevent infections among individuals with autoimmune rheumatic diseases (ARDs), ultimately improving the quality of life and reducing mortality. The incorporation of vaccination strategies into clinical decision-making processes has been recognized as pivotal. However, the absence of clinical guidelines and consensus on vaccination for ARDs patients still persists in China. Drawing from existing clinical evidence, this expert consensus encompasses eight prevalent vaccines: Influenza vaccine, pneumococcal polysaccharide vaccine, COVID-19 vaccine, herpes zoster vaccine, human papillomavirus vaccine, hepatitis A vaccine, hepatitis B vaccine, and rabies virus vaccine...
January 6, 2024: Zhonghua Yu Fang Yi Xue za Zhi [Chinese Journal of Preventive Medicine]
https://read.qxmd.com/read/38221914/molecular-genetic-association-of-rs8099917-and-rs1800795-polymorphisms-in-the-progression-of-hepatitis-delta-virus-liver-disease
#39
JOURNAL ARTICLE
Ana Maísa Passos-Silva, Eugênia de Castro E Silva, Lourdes Maria Pinheiro Borzacov, Adrhyan Araújo, Anita Sperandio Porto, Juan Miguel Villalobos Salcedo, Deusilene Vieira
BACKGROUND: The relationship between viral infections and host factors holds high hopes for identifying the role of Interferon Lambda 3 (IFNL3) and Interleukin 6 (IL-6) polymorphisms in the development of Chronic Liver Disease (CLD) in patients infected with hepatitis Delta virus (HDV) in the Western Brazilian Amazon. METHODS: Cross-sectional study conducted with a cohort of 40 chronic HDV patients, 27 with CLD and 13 without evident liver damage. Biological samples from the participants were analyzed using the polymerase chain reaction (PCR) technique, followed by sequencing by the automated Sanger method...
2024: Journal of Venomous Animals and Toxins Including Tropical Diseases
https://read.qxmd.com/read/38218378/the-prevalence-of-hdv-among-hbsag-positive-populations-with-and-without-hiv-1-in-china
#40
JOURNAL ARTICLE
Yan Wang, Guizhou Shen, Ruichao Lu, Jun Liu, Feng Zhang, Hui Wang, Weiping Cai, Fujie Zhang
BACKGROUND: Existing research has provided evidence of changes in hepatitis delta virus (HDV) prevalence worldwide. This study aimed to investigate the prevalence and molecular characteristics of HDV to elucidate its spread in China. METHODS: A total of 3,000 samples were collected from 2,241 HBV monoinfections and 759 HBV/HIV-1 coinfections across 13 sites in northern, southern, western, and southwestern China. Serological and virological prevalence were determined by detecting anti-HDV antibodies and HDV RNA...
January 11, 2024: International Journal of Infectious Diseases: IJID
keyword
keyword
12513
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.